75 FR 244 pgs. 79955-79956 - New Animal Drugs; Change of Sponsor's Address
Type: RULEVolume: 75Number: 244Pages: 79955 - 79956
Docket number: [Docket No. FDA-2010-N-0002]
FR document: [FR Doc. 2010-31952 Filed 12-20-10; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
[Docket No. FDA-2010-N-0002]
New Animal Drugs; Change of Sponsor's Address
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of address for Intervet, Inc., a sponsor of approved new animal drug applications.
DATES:
This rule is effective December 21, 2010.
FOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, e-mail: steven.vaughn@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
Intervet, Inc., 56 Livingston Ave., Roseland, NJ 07068 has informed FDA that it has changed its address to 556 Morris Ave., Summit, NJ 07901. Accordingly, the Agency is amending the regulations in 21 CFR 510.600 to reflect this change.
This rule does not meet the definition of "rule" in 5 U.S.C. 804(3)(A) because it is a rule of "particular applicability." Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:
PART 510-NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as follows:
Authority:
21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
2. In § 510.600, in the table in paragraph (c)(1), revise the entry for "Intervet, Inc."; and in the table in paragraph (c)(2), revise the entry for "000061" to read as follows:
§ 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications.
(c) * * *
(1) * * *
| Firm name and address | Drug labeler code |
|---|---|
| ******* | |
| Intervet, Inc., 556 Morris Ave., Summit, NJ 07901 | 000061 |
| ******* |
(2) * * *
| Drug labeler code | Firm name and address |
|---|---|
| ******* | |
| 000061 | Intervet, Inc., 556 Morris Ave., Summit, NJ 07901. |
| ******* |
Dated: December 9, 2010.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 2010-31952 Filed 12-20-10; 8:45 am]
BILLING CODE 4160-01-P